466 related articles for article (PubMed ID: 27252617)
1. Multi-Target Directed Donepezil-Like Ligands for Alzheimer's Disease.
Unzeta M; Esteban G; Bolea I; Fogel WA; Ramsay RR; Youdim MB; Tipton KF; Marco-Contelles J
Front Neurosci; 2016; 10():205. PubMed ID: 27252617
[TBL] [Abstract][Full Text] [Related]
2. ASS234, As a New Multi-Target Directed Propargylamine for Alzheimer's Disease Therapy.
Marco-Contelles J; Unzeta M; Bolea I; Esteban G; Ramsay RR; Romero A; Martínez-Murillo R; Carreiras MC; Ismaili L
Front Neurosci; 2016; 10():294. PubMed ID: 27445665
[TBL] [Abstract][Full Text] [Related]
3. Donepezil + propargylamine + 8-hydroxyquinoline hybrids as new multifunctional metal-chelators, ChE and MAO inhibitors for the potential treatment of Alzheimer's disease.
Wang L; Esteban G; Ojima M; Bautista-Aguilera OM; Inokuchi T; Moraleda I; Iriepa I; Samadi A; Youdim MB; Romero A; Soriano E; Herrero R; Fernández Fernández AP; Ricardo-Martínez-Murillo ; Marco-Contelles J; Unzeta M
Eur J Med Chem; 2014 Jun; 80():543-61. PubMed ID: 24813882
[TBL] [Abstract][Full Text] [Related]
4. Multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer's disease: design, synthesis, biochemical evaluation, ADMET, molecular modeling, and QSAR analysis of novel donepezil-pyridyl hybrids.
Bautista-Aguilera OM; Esteban G; Chioua M; Nikolic K; Agbaba D; Moraleda I; Iriepa I; Soriano E; Samadi A; Unzeta M; Marco-Contelles J
Drug Des Devel Ther; 2014; 8():1893-910. PubMed ID: 25378907
[TBL] [Abstract][Full Text] [Related]
5. Key Targets for Multi-Target Ligands Designed to Combat Neurodegeneration.
Ramsay RR; Majekova M; Medina M; Valoti M
Front Neurosci; 2016; 10():375. PubMed ID: 27597816
[TBL] [Abstract][Full Text] [Related]
6. 6-Methyluracil derivatives as acetylcholinesterase inhibitors for treatment of Alzheimer's disease.
Zueva IV; Semenov VE; Mukhamedyarov MA; Lushchekina SV; Kharlamova AD; Petukhova EO; Mikhailov AS; Podyachev SN; Saifina LF; Petrov KA; Minnekhanova OA; Zobov VV; Nikolsky EE; Masson P; Reznik VS
Int J Risk Saf Med; 2015; 27 Suppl 1():S69-71. PubMed ID: 26639718
[TBL] [Abstract][Full Text] [Related]
7. A comprehensive review of multi-target directed ligands in the treatment of Alzheimer's disease.
Pathak C; Kabra UD
Bioorg Chem; 2024 Mar; 144():107152. PubMed ID: 38290187
[TBL] [Abstract][Full Text] [Related]
8. A Recent Appraisal of Small-Organic Molecules as Anti-Alzheimer's Agents.
Gupta M; Kumar A; Ojha M; Khan SK; Nain S
Mini Rev Med Chem; 2023; 23(8):962-976. PubMed ID: 36154572
[TBL] [Abstract][Full Text] [Related]
9. Sarsasapogenin: A steroidal saponin from Asparagus racemosus as multi target directed ligand in Alzheimer's disease.
Kashyap P; Muthusamy K; Niranjan M; Trikha S; Kumar S
Steroids; 2020 Jan; 153():108529. PubMed ID: 31672628
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, and biological evaluation of novel donepezil-tacrine hybrids as multi-functional agents with low neurotoxicity against Alzheimer's disease.
Wang N; Jia W; Wang J; Yang Z; Liu Y; Huang D; Mei X; Xiong X; Shi J; Tang Y; Chen G; Di D; Hou Y; Liu Y
Bioorg Chem; 2024 Feb; 143():107010. PubMed ID: 38056387
[TBL] [Abstract][Full Text] [Related]
11. Novel Coumarin-Pyridine Hybrids as Potent Multi-Target Directed Ligands Aiming at Symptoms of Alzheimer's Disease.
Babaei E; Küçükkılınç TT; Jalili-Baleh L; Nadri H; Öz E; Forootanfar H; Hosseinzadeh E; Akbari T; Ardestani MS; Firoozpour L; Foroumadi A; Sharifzadeh M; Mirjalili BBF; Khoobi M
Front Chem; 2022; 10():895483. PubMed ID: 35844650
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, pharmacological evaluation, QSAR analysis, molecular modeling and ADMET of novel donepezil-indolyl hybrids as multipotent cholinesterase/monoamine oxidase inhibitors for the potential treatment of Alzheimer's disease.
Bautista-Aguilera OM; Esteban G; Bolea I; Nikolic K; Agbaba D; Moraleda I; Iriepa I; Samadi A; Soriano E; Unzeta M; Marco-Contelles J
Eur J Med Chem; 2014 Mar; 75():82-95. PubMed ID: 24530494
[TBL] [Abstract][Full Text] [Related]
13. Management of oxidative stress and other pathologies in Alzheimer's disease.
Simunkova M; Alwasel SH; Alhazza IM; Jomova K; Kollar V; Rusko M; Valko M
Arch Toxicol; 2019 Sep; 93(9):2491-2513. PubMed ID: 31440798
[TBL] [Abstract][Full Text] [Related]
14. Development of the "hidden" multi-target-directed ligands by AChE/BuChE for the treatment of Alzheimer's disease.
Chen R; Li X; Chen H; Wang K; Xue T; Mi J; Ban Y; Zhu G; Zhou Y; Dong W; Tang L; Sang Z
Eur J Med Chem; 2023 May; 251():115253. PubMed ID: 36921526
[TBL] [Abstract][Full Text] [Related]
15. Unleashing new MTDL AChE and BuChE inhibitors as potential anti-AD therapeutic agents: In vitro, in vivo and in silico studies.
Zaafar D; Elghazawy NH; Hassan A; Mahmoud MY; Bakr AF; Arafa RK
Int J Biol Macromol; 2024 May; 268(Pt 1):131740. PubMed ID: 38653428
[TBL] [Abstract][Full Text] [Related]
16. Design, Synthesis, and In Vitro Evaluation of Hydroxybenzimidazole-Donepezil Analogues as Multitarget-Directed Ligands for the Treatment of Alzheimer's Disease.
Chaves S; Resta S; Rinaldo F; Costa M; Josselin R; Gwizdala K; Piemontese L; Capriati V; Pereira-Santos AR; Cardoso SM; Santos MA
Molecules; 2020 Feb; 25(4):. PubMed ID: 32098407
[TBL] [Abstract][Full Text] [Related]
17. Antioxidant and Cholinesterase Inhibitory Activities of Ethyl Acetate Extract of
Rajmohamed MA; Natarajan S; Palanisamy P; Abdulkader AM; Govindaraju A
Pharmacogn Mag; 2017 Oct; 13(Suppl 3):S437-S445. PubMed ID: 29142396
[TBL] [Abstract][Full Text] [Related]
18. Cyanobiphenyls: Novel H
Godyń J; Zaręba P; Łażewska D; Stary D; Reiner-Link D; Frank A; Latacz G; Mogilski S; Kaleta M; Doroz-Płonka A; Lubelska A; Honkisz-Orzechowska E; Olejarz-Maciej A; Handzlik J; Stark H; Kieć-Kononowicz K; Malawska B; Bajda M
Bioorg Chem; 2021 Sep; 114():105129. PubMed ID: 34217977
[TBL] [Abstract][Full Text] [Related]
19. Design Synthesis and
Remya RS; Ramalakshmi N; Nalini CN; Niraimathi V; Amuthalakshmi S
Curr Comput Aided Drug Des; 2022; 18(4):271-292. PubMed ID: 35927818
[TBL] [Abstract][Full Text] [Related]
20. Donepezil-based hybrids as multifunctional anti-Alzheimer's disease chelating agents: Effect of positional isomerization.
Costa M; Josselin R; Silva DF; Cardoso SM; May NV; Chaves S; Santos MA
J Inorg Biochem; 2020 May; 206():111039. PubMed ID: 32171933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
